Web Results

en.wikipedia.org/wiki/Takeda_Pharmaceutical_Company

Takeda Pharmaceutical Company Ltd is the largest pharmaceutical company in Japan and Asia and a top 15 pharmaceutical company in the world. The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, ...

www.takeda.us

As a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is among the top 15 pharmaceutical companies in the United States. TPUSA was founded in 1998 to accelerate Takeda's global expansion into the U.S. market. Takeda's U.S. clinical development ...

www.takeda.us/home/contact_us.aspx

Contact Reason, Contact Information. Adverse Events and Product Complaints , 877-TAKEDA7 (877-825-3327). Medical Information, 877-TAKEDA7 ...

www.takeda.us/careers

At Takeda, we are determined to lead the change for a better world. For more than 230 years, our innovative medicines have been helping patients reclaim ...

www.takeda.us/about_takeda

Takeda Pharmaceuticals U.S.A., Inc. ( TPUSA) is committed to strive toward better health for people worldwide through leading innovation in medicine.

www.takeda.com/who-we-are/company-information/worldwide-offices/Takeda-Pharmaceuticals-USA-Inc

Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is committed to strive toward better health for patients through leading innovation in medicine. It is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company and one with a 230-year heritage. TPUSA currently markets ...

www.takeda.com

Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology , gastroenterology and central nervous system therapeutic areas plus vaccines.

www.takeda.com/newsroom

December 15, 2017 12/15/2017 Takeda and TiGenix announce that Cx601 ( darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease. December 10, 2017 12/10/2017 Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ...

www.drugs.com/manufacturer/takeda-pharmaceuticals-u-s-a-inc-137.html

Takeda Pharmaceuticals U.S.A., Inc. manufactures, markets and/or distributes more than 24 drugs in the U.S..